Brief: Bd Receives FDA 510(K) Clearance For First-Of-Its-Kind High-Throughput Diagnostic Test For Infectious Vaginitis
16/03/2023 11:41
March 16 (Reuters) - Becton Dickinson and Co BDX.N :
* BD RECEIVES FDA 510(K) CLEARANCE FOR FIRST-OF-ITS-KIND
HIGH-THROUGHPUT DIAGNOSTIC TEST FOR INFECTIOUS VAGINITIS
Source text for Eikon: ID:nPnbpdtrPa
Further company coverage: BDX.N
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Becton Dickinson and Co
See all newsCorrected: BDx secures data center power contract from Indonesia's PLN
China's commerce ministry holds meeting with foreign pharmaceutical firms
Brief: Becton Dickinson Euro Finance S.À R.L Files For Euro-Denominated 600 Million 3.855% Notes Offering Due 2033 - SEC Filing
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
Becton Dickinson raises 2026 profit forecast on drug delivery devices demand (updated)